The Cooper Companies, Inc (COO) is a Healthcare · Medical Instruments & Supplies company listed on NASDAQ. Price $55.29 (+2.82%), Market cap $11.51B, P/E ratio 29.34, 52-week low–high $58.98 ~ $84.32.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, an
Financial statements, price targets, institutional (13F) holdings and related news for The Cooper Companies, Inc are updated in real time on BlackAll Trade.
The Cooper Companies, Inc trades at $55.29 (+2.82%). Real-time quotes and charts are available on BlackAll Trade.
The Cooper Companies, Inc has a market cap of about $11.51B. Its P/E ratio is 29.34.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperV